Medpace Holdings, Inc. Reimbursement Revenue (Deprecated 2018-01-31)
Medpace Holdings, Inc. (MEDP) reported Reimbursement Revenue (Deprecated 2018-01-31) of $0 for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-01.
Discontinued › Income Statement › Other Income
us-gaap:ReimbursementRevenue · last filed 2018-05-01
- Medpace Holdings, Inc. reimbursement revenue (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $0.00, a 100.00% decline year-over-year.
- Medpace Holdings, Inc. reimbursement revenue (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $13.23M, a 2.85% increase year-over-year.
- Medpace Holdings, Inc. reimbursement revenue (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $11.96M, a 7.89% decline year-over-year.
- Medpace Holdings, Inc. reimbursement revenue (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $11.66M, a 12.44% decline year-over-year.
- Medpace Holdings, Inc. reimbursement revenue (deprecated 2018-01-31) for fiscal 2017 was $49.69M, a 2.49% decline from fiscal 2016.
- Medpace Holdings, Inc. reimbursement revenue (deprecated 2018-01-31) for fiscal 2016 was $50.96M, a 30.81% increase from fiscal 2015.
- Medpace Holdings, Inc. reimbursement revenue (deprecated 2018-01-31) for fiscal 2015 was $38.96M.
| Period end | Reimbursement Revenue (Deprecated 2018-01-31) 3 month | Reimbursement Revenue (Deprecated 2018-01-31) 6 month | Reimbursement Revenue (Deprecated 2018-01-31) 9 month | Reimbursement Revenue (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2018-03-31 | $0.00 10-Q · filed 2018-05-01 | $13.23M derived: sum of 2 quarters · filed 2018-05-01 | $25.20M derived: sum of 3 quarters · filed 2018-05-01 | $36.86M derived: sum of 4 quarters · filed 2018-05-01 |
| 2017-12-31 | $13.23M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $25.20M derived: sum of 2 quarters · filed 2018-02-27 | $36.86M derived: sum of 3 quarters · filed 2018-02-27 | $49.69M 10-K · filed 2018-02-27 |
| 2017-09-30 | $11.96M 10-Q · filed 2017-10-31 | $23.63M derived: sum of 2 quarters · filed 2017-10-31 | $36.46M 10-Q · filed 2017-10-31 | $49.32M derived: sum of 4 quarters · filed 2018-05-01 |
| 2017-06-30 | $11.66M 10-Q · filed 2017-08-01 | $24.49M 10-Q · filed 2017-08-01 | $37.36M derived: sum of 3 quarters · filed 2018-05-01 | $50.35M derived: sum of 4 quarters · filed 2018-05-01 |
| 2017-03-31 | $12.83M 10-Q · filed 2018-05-01 | $25.70M derived: sum of 2 quarters · filed 2018-05-01 | $38.68M derived: sum of 3 quarters · filed 2018-05-01 | $52.01M derived: sum of 4 quarters · filed 2018-05-01 |
| 2016-12-31 | $12.87M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $25.85M derived: sum of 2 quarters · filed 2018-02-27 | $39.17M derived: sum of 3 quarters · filed 2018-02-27 | $50.96M 10-K · filed 2018-02-27 |
| 2016-09-30 | $12.99M 10-Q · filed 2017-10-31 | $26.31M derived: sum of 2 quarters · filed 2017-10-31 | $38.09M 10-Q · filed 2017-10-31 | $48.45M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $13.32M 10-Q · filed 2017-08-01 | $25.11M 10-Q · filed 2017-08-01 | $35.47M derived: sum of 3 quarters · filed 2018-02-27 | $45.96M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $11.79M 10-Q · filed 2017-05-02 | $22.15M derived: sum of 2 quarters · filed 2018-02-27 | $32.64M derived: sum of 3 quarters · filed 2018-02-27 | |
| 2015-12-31 | $10.36M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $20.85M derived: sum of 2 quarters · filed 2018-02-27 | $38.96M 10-K · filed 2018-02-27 | |
| 2015-09-30 | $10.49M 10-Q · filed 2016-11-03 | $28.60M 10-Q · filed 2016-11-03 | ||
| 2014-12-31 | $28.71M 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |